Skip to content
biote Corp icon

biote Corp

BTMDStocksHospital Or Nursing ManagementUnited StatesNasdaqUSD

Price

$1.14

Today

-0.9%

YTD

-55.3%

About

biote Corp. is a leading provider of hormone optimisation therapy within the U.S., which aims to restore hormone levels to optimal ranges for patients experiencing symptoms of hormone imbalance. The company's proprietary approach utilises bioidentical hormones, which are chemically identical to those produced by the human body. Operating in the healthcare sector, biote Corp. offers a comprehensive suite of hormone optimisation services, including hormone testing, consultation, and treatment. Stay up to date on the latest share price changes by adding BTMD stock to your eToro watchlist.

Price chart
Closing price history for BTMD (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)9.55
P/S (TTM)0.18
P/B (TTM)-0.48
Market cap$32.98M
Cap tierMicro-cap
Industry avg P/E-18.38

Profitability

Gross margin66.93%
EBIT margin12.03%
Net margin-14.84%
ROEUnknown
ROA5.67%

Earnings & Revenue

Revenue (TTM)$183.53M
Revenue growth (1Y)-7.8%
EPS (TTM)$0.12
Free cash flow$19.87M
Total debt$128.64M

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.32
Employees223
Next earnings4 Nov '26
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.

biote Corp (BTMD) | Dirk Kuyken